In a significant step forward for India’s cancer treatment, Immuneel Therapeutics (Immuneel), proudly unveils Qartemi®, country’s first global CAR T-cell therapy for adult B-cell Non-Hodgkin Lymphoma (B-NHL). A personalized therapy for adult patients with relapsed or refractory B-NHL, Immuneel, India’s leading cell and gene therapy start-up, addresses a critical gap in India’s cancer immunotherapy landscape. This groundbreaking therapy—benchmarked to global […]
Top News
Tag: B-cell Non-Hodgkin Lymphoma
Back To Top